SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is experiencing a sharp sell-off as a weak revenue outlook and concerns over its turnaround timeline in Greater China triggered institutional downgrades and automated selling cascades. While many community members are debating whether this marks a bottom for a long-term value play or a structural decline for a "woke" brand, others are capitalizing on the extreme oversold conditions to accumulate positions near decade-low price levels.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is currently trending as investors weigh recent capital allocation moves, including a multi-billion dollar stake repurchase in its Irish manufacturing site, against broader market volatility and geopolitical concerns affecting the semiconductor sector. While the community remains divided between long-term bulls highlighting foundry expansion and AI growth and short-term bears skeptical of manufacturing headwinds, active discussion is dominated by the stock's pronounced intraday volatility and its sensitivity to macroeconomic headlines.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors react to the company's fiscal Q3 earnings report, which highlighted record revenue and international growth, though community sentiment remains polarized over management and the stock's long-term performance. While some participants are betting on an upside reversal tied to broader cannabis sector catalysts and rescheduling prospects, others remain skeptical, citing concerns over dilution and historical share price declines.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as investors digest positive Week 40 Phase 3 data, which demonstrates that sonelokimab sets a new standard in lesion control and durability for hidradenitis suppurativa. The community is actively debating the stock's significant long-term potential and clinical differentiation against incumbents, while many speculate that the upcoming institutional meetings and clinical milestones will catalyze a major repricing or buyout event.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors await the upcoming 10-K filing and earnings report, with the community closely tracking aggressive debt reduction efforts and the performance of key holdings like Applied Digital and BW. Bullish sentiment remains high among retail investors, who are actively discussing a potential valuation re-rating and the possibility of a short squeeze as the company works to resolve past narrative overhangs.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility as investors debate the impact of potential memory compression technologies on future demand versus strong long-term AI-driven storage needs. The community remains deeply divided, with some traders actively shorting into the price swings while others emphasize valuation metrics and anticipate a rebound leading up to upcoming quarterly earnings.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending as investors weigh significant commercial potential from its recently approved drug, Yartemlea, against broader market pressure and aggressive short interest. The community is actively debating the stock's valuation, the impact of recent milestone payments from Novo Nordisk, and the potential for a short squeeze as traders watch for upcoming financial results and European regulatory updates.

RH operates as a holding company which operates the business through its subsidiary Restoration Hardware, Inc. It offers furniture, lighting, textiles, bath ware, decor, outdoor and garden, as well as baby and child products. The company operates an integrated business with multiple channels of distribution including galleries, source books and websites. The company was founded by Stephen J. Gordon in 1980 and is headquartered in Corte Madera, CA.

RH - Ordinary Shares - Class A

Restoration Hardware

Restoration Hardware is currently experiencing intense volatility following a significant earnings miss and lowered guidance, with the stock drawing heavy attention due to its massive short interest and the ongoing debate over whether it is a value play or a potential bankruptcy candidate. The community is sharply divided, with bulls betting on a short squeeze and long-term luxury market recovery, while bears point to persistent housing market headwinds, tariff-related margin compression, and expensive international expansion as signs of long-term deterioration.

SharonAI Holdings, Inc. engages in providing high-performance computing (HPC), artificial intelligence (AI), and cloud GPU compute infrastructure technologies. The company was founded on December 30, 2024 and is headquartered in New York, NY.

SharonAI Holdings Inc. - Ordinary Shares - Class A

SharonAI is trending following the announcement of a massive multi-year AI cloud infrastructure contract, which has triggered intense community debate over its low-float potential and possible short-squeeze dynamics. Investors are actively analyzing the company's valuation shift while discussing the impact of thin trading volume and the technical setup on the stock price.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is seeing significant speculative activity as traders draw comparisons to its past parabolic runs, fueled by a combination of tight float, high short interest, and persistent community speculation regarding a potential meme-style short squeeze. While bulls are actively targeting rapid gains and waiting for volume-driven breakouts, a vocal segment of the community remains skeptical, frequently highlighting the company's lack of revenue and warning others about the risks of being left as exit liquidity in a pump-and-dump setup.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Uranium Royalty (NASDAQ:UROY) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised shares of Uranium Royalty from a "hold" rating to a "buy" rating in a research note on Saturday...

Uranium Royalty (TSE:URC) Trading Down 2.8% - What's Next?

Uranium Royalty (TSE:URC) Shares Down 2.8% - Should You Sell...

Uranium Royalty (NASDAQ:UROY) Shares Gap Down - Time to Sell?

Uranium Royalty (NASDAQ:UROY) Shares Gap Down - Should You Sell...

Uranium Royalty (NASDAQ:UROY) Issues Earnings Results, Beats Expectations By $0.02 EPS

Uranium Royalty (NASDAQ:UROY - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.01 earnings per share for the quarter, beating the consensus estimate of ($0.01...

Uranium Royalty (UROY) Projected to Post Earnings on Thursday

Uranium Royalty (NASDAQ:UROY) will be releasing its Q3 2026 earnings before the market opens on Thursday, March 5. (View Earnings Report at...

Uranium Royalty (TSE:URC) Stock Price Up 3.5% - Time to Buy?

Uranium Royalty (TSE:URC) Stock Price Up 3.5% - What's Next...

CenterBook Partners LP Has $2.06 Million Stake in Uranium Royalty Corp. $UROY

CenterBook Partners LP reduced its stake in shares of Uranium Royalty Corp. (NASDAQ:UROY - Free Report) by 40.8% in the third quarter, according to its most recent filing with the SEC. The...

Uranium Royalty Corp. (NASDAQ:UROY) Receives Average Rating of "Hold" from Analysts

Shares of Uranium Royalty Corp. (NASDAQ:UROY - Get Free Report) have earned an average recommendation of "Hold" from the five analysts that are covering the firm, Marketbeat Ratings reports. One...

Acuitas Investments LLC Increases Position in Uranium Royalty Corp. $UROY

Acuitas Investments LLC boosted its stake in shares of Uranium Royalty Corp. (NASDAQ:UROY - Free Report) by 120.9% in the third quarter, according to its most recent filing with the Securities and...

Uranium Royalty (NASDAQ:UROY) Stock Price Down 14.2% - Time to Sell?

Uranium Royalty (NASDAQ:UROY) Trading Down 14.2% - Time to Sell...

Uranium Royalty Corp. operates as an exploration company, which engages in acquiring and assembling a portfolio of royalties, and investing in companies with exposure to uranium and physical uranium. The company was founded by Amir Adnani on April 21, 2017 and is headquartered in Vancouver, Canada.

Uranium Royalty Corp

Thematic ETFs

Prediction Markets

OpenClaw & Agentic-Directed Trading

Tokenization

Recognizing the tool or mechanism that redefined how we trade. From prediction markets to next-gen tech, this award honors the innovation that pushed the boundaries of access and efficiency in modern finance.

UROY
Uranium Royalty Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest UROY News

UROYUranium Royalty Corp